Oxidative Medicine and Cellular Longevity, 2022 · DOI: https://doi.org/10.1155/2022/5918218 · Published: December 2, 2022
Peripheral nerve injury (PNI) can lead to sensory and motor dysfunction. Exploration of PNI mechanisms is required due to high disability rates. Ferroptosis, a novel form of cell death, is iron-dependent and involves multiple cellular metabolic pathways. Inhibition of ferroptosis can promote nerve repair and recovery. Iron metabolism needs strict regulation in the human body. Abnormal iron metabolism is closely associated with the defective repair process after a damage to the nervous system. Ferroptosis, first defined in 2012, is a new form of regulated cell death (RCD), which is dependent on iron ions. After PNI, a microenvironment is established with increased iron ions and ROS levels, contributing to ferroptosis. This causes further damage to Schwann cells and axons, exacerbating nerve damage, neuropathic pain, or neuroinflammation.
Targeting ferroptosis pathways may provide new therapeutic strategies for treating peripheral nerve injuries.
Developing specific inhibitors of ferroptosis could help in alleviating tissue damage and promoting functional recovery post-PNI.
Further research, including clinical trials, is needed to validate anti-ferroptosis treatment strategies for PNI in humans.